|
Journal of Lipid Research, Vol. 43, 671-675, May 2002
Copyright © 2002 by Lipid Research, Inc.
Identification of mouse and human macrophages as a site of synthesis of hepatic lipase
Herminia González-Navarro1,*,
Zengxuan Nong*,
Lita Freeman*,
André Bensadoun2, ,
Katherine Peterson* and
Silvia Santamarina-Fojo*
* Molecular Disease Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892
Division of Nutritional Sciences, Cornell University, Ithaca, NY 14852
1 To whom correspondence should be addressed. e-mail: gonza{at}mail.nih.gov
ABSTRACT
Hepatic lipase (HL) is synthesized by the liver and is also present in steroidogenic tissues. As both a lipolytic enzyme and a ligand that facilitates the cellular uptake of lipoproteins, HL plays a major role in lipoprotein metabolism and may modulate atherogenic risk. However, HL has not been directly implicated in lesion development. In the present study we demonstrate that HL is also synthesized by mouse and human macrophages. Northern analysis and real time RT-PCR showed that HL mRNA is present in mouse peritoneal macrophages, RAW-264.7, and IC-21 cells. The levels of HL mRNA in mouse peritoneal macrophages were approximately 1030% that of mouse liver. HL protein was identified by Western blot analyses in human monocyte-derived macrophages, THP, RAW-264.7, and mouse peritoneal macrophages following fractionation by heparin-sepharose affinity chromatography. These combined findings establish that HL is synthesized de novo by macrophages as well as liver, and raises the possibility that HL may have a direct role in the pathogenesis of atherosclerosis.González-Navarro, H., Z. Nong, L. Freeman, A. Bensadoun, K. Peterson, S. Santamarina-Fojo. Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J. Lipid Res. 2002. 43: 671675.
Abbreviations: HL, hepatic lipase; apo, apolipoprotein Supplementary key words lipoprotein lipase lipoproteins RAW 264.7 THP

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. H. Doolittle, O. Ben-Zeev, S. Bassilian, J. P. Whitelegge, M. Peterfy, and H. Wong
Hepatic lipase maturation: a partial proteome of interacting factors
J. Lipid Res.,
June 1, 2009;
50(6):
1173 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Hime, A. S. Black, J. J. Bulgrien, and L. K. Curtiss
Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP
J. Lipid Res.,
October 1, 2008;
49(10):
2113 - 2123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Freeman, M. J. A. Amar, R. Shamburek, B. Paigen, H. B. Brewer Jr., S. Santamarina-Fojo, and H. Gonzalez-Navarro
Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice
J. Lipid Res.,
January 1, 2007;
48(1):
104 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Karackattu, B. Trigatti, and M. Krieger
Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2006;
26(3):
548 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Curtiss, D. T. Valenta, N. J. Hime, and K.-A. Rye
What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2006;
26(1):
12 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Oram and J. W. Heinecke
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
Physiol Rev,
October 1, 2005;
85(4):
1343 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Fan, P. Dastidar, H. Jokela, R. Punnonen, and T. Lehtimaki
Hepatic Lipase C-480T Genotype-Dependent Benefit from Long-Term Hormone Replacement Therapy for Atherosclerosis Progression in Postmenopausal Women
J. Clin. Endocrinol. Metab.,
June 1, 2005;
90(6):
3786 - 3792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Lee, S. Kadambi, K. C-W. Yu, C. David, S. Azhar, A. D. Cooper, and S. Y. Choi
Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase
J. Lipid Res.,
January 1, 2005;
46(1):
27 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gonzalez-Navarro, Z. Nong, M. J. A. Amar, R. D. Shamburek, J. Najib-Fruchart, B. J. Paigen, H. B. Brewer Jr., and S. Santamarina-Fojo
The Ligand-binding Function of Hepatic Lipase Modulates the Development of Atherosclerosis in Transgenic Mice
J. Biol. Chem.,
October 29, 2004;
279(44):
45312 - 45321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Santamarina-Fojo, H. Gonzalez-Navarro, L. Freeman, E. Wagner, and Z. Nong
Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2004;
24(10):
1750 - 1754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y M Fan, J T Salonen, T A Koivu, T-P Tuomainen, K Nyyssonen, T A Lakka, R Salonen, K Seppanen, S T Nikkari, E Tahvanainen, et al.
Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study
J. Med. Genet.,
March 1, 2004;
41(3):
e28 - 28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ben-Zeev and M. H. Doolittle
Maturation of Hepatic Lipase: FORMATION OF FUNCTIONAL ENZYME IN THE ENDOPLASMIC RETICULUM IS THE RATE-LIMITING STEP IN ITS SECRETION
J. Biol. Chem.,
February 13, 2004;
279(7):
6171 - 6181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Yancey, M.-a. Kawashiri, R. Moore, J. M. Glick, D. L. Williams, M. A. Connelly, D. J. Rader, and G. H. Rothblat
In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux
J. Lipid Res.,
February 1, 2004;
45(2):
337 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Desrumaux, P. A. Mak, W. A. Boisvert, D. Masson, D. Stupack, M. Jauhiainen, C. Ehnholm, and L. K. Curtiss
Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells
J. Lipid Res.,
August 1, 2003;
44(8):
1453 - 1461.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|